Inotiv, Inc. (NASDAQ:NOTV) Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC lowered its position in shares of Inotiv, Inc. (NASDAQ:NOTV) by 5.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 237,852 shares of the company’s stock after selling 13,043 shares during the period. Geode Capital Management LLC owned 0.91% of Inotiv worth $985,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of NOTV. Thurston Springer Miller Herd & Titak Inc. lifted its position in shares of Inotiv by 612.5% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 127,257 shares of the company’s stock worth $527,000 after buying an additional 109,397 shares during the last quarter. KPP Advisory Services LLC raised its stake in Inotiv by 15.8% during the 4th quarter. KPP Advisory Services LLC now owns 275,267 shares of the company’s stock worth $1,140,000 after acquiring an additional 37,549 shares in the last quarter. Vantage Point Financial LLC purchased a new stake in Inotiv in the fourth quarter valued at $1,393,000. Calamos Advisors LLC acquired a new position in Inotiv in the fourth quarter valued at $275,000. Finally, Nkcfo LLC purchased a new position in shares of Inotiv during the fourth quarter worth about $476,000. Hedge funds and other institutional investors own 18.17% of the company’s stock.

Insider Buying and Selling at Inotiv

In related news, CEO Robert Jr. Leasure sold 73,617 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $3.82, for a total transaction of $281,216.94. Following the transaction, the chief executive officer now owns 956,592 shares of the company’s stock, valued at $3,654,181.44. This trade represents a 7.15 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Over the last three months, insiders have sold 81,439 shares of company stock worth $312,475. 7.80% of the stock is owned by company insiders.

Inotiv Stock Up 0.5 %

NOTV opened at $1.98 on Friday. Inotiv, Inc. has a one year low of $1.15 and a one year high of $6.48. The company has a debt-to-equity ratio of 2.31, a quick ratio of 1.28 and a current ratio of 1.57. The stock has a market capitalization of $66.76 million, a P/E ratio of -0.43 and a beta of 3.96. The business’s 50-day simple moving average is $2.43 and its 200-day simple moving average is $3.24.

Inotiv (NASDAQ:NOTV) last issued its quarterly earnings data on Wednesday, February 5th. The company reported ($0.42) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.10). Inotiv had a negative net margin of 25.40% and a negative return on equity of 15.41%. Analysts anticipate that Inotiv, Inc. will post -0.79 EPS for the current year.

Inotiv Company Profile

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.